|
|
Volumn 66, Issue 5, 2002, Pages 365-368
|
|
Microbicides - Evaluating multiple formulations of C31G
a
|
|
Author keywords
C31G; Clinical trial; Microbicide; STD
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
C 31G;
COPOLYMER;
HYDROXYETHYLCELLULOSE;
UNCLASSIFIED DRUG;
BETAINE;
DRUG DERIVATIVE;
UNSATURATED FATTY ACID;
ADULT;
ALGORITHM;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG FORMULATION;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
FOLLOW UP;
HUMAN;
IN VITRO STUDY;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
PATHOGENESIS;
PHASE 1 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
SEXUALLY TRANSMITTED DISEASE;
TREATMENT OUTCOME;
ADOLESCENT;
CHEMISTRY;
DRUG ADMINISTRATION;
INTRAVAGINAL DRUG ADMINISTRATION;
MIDDLE AGED;
PATIENT SATISFACTION;
UNITED KINGDOM;
UNITED STATES;
ADMINISTRATION, INTRAVAGINAL;
ADOLESCENT;
ADULT;
ANTI-INFECTIVE AGENTS;
BETAINE;
CHEMISTRY, PHARMACEUTICAL;
DRUG ADMINISTRATION SCHEDULE;
ENGLAND;
FATTY ACIDS, UNSATURATED;
FEMALE;
HUMANS;
MIDDLE AGED;
NORTH CAROLINA;
PATIENT SATISFACTION;
PENNSYLVANIA;
SEXUALLY TRANSMITTED DISEASES;
|
|
EID: 0036849414
PISSN: 00107824
EISSN: None
Source Type: Journal
DOI: 10.1016/S0010-7824(02)00389-X Document Type: Article |
|
Times cited : (42)
|
|
References (9)
|
